Introduction
Tetanus is a highly fatal disease caused by a neurotoxin of a gram positive and anaerobic bacterium of the Clostridium genous, Clostridium tetani
(1). TeNT and seven botulinum neurotoxins (BoNT/A-G) make the family of clostridial neurotoxins (CNTs), which are exclusively responsible for neuroparalytic syndromes of tetanus and botulism (2).
TeNT is produced as a single polypeptide (approximately 150 kDa) and subsequentlycleaved to a two-chain active holotoxin, in which a 50 kDa N-terminal Light Chain (LC) and a 100 kDa C-terminal Heavy Chain (HC) are linked by a single disulphide bond (3, 4).
Tetanus toxin light chain holds the HEXXH zinc protease consensus motif and acts as a toxic part of toxin and zinc-dependent endopeptidase (5, 6). Tetanus toxin HC is composed of the aminoterminal half (HN~50 kDa) which is important for LC translocation andthe carboxyterminal half (HC or fragment C~50 kDa) which holds the key amino acid residues responsible for the binding activity of the CNTs (7). Fragment C or the carboxyterminal half of HC is further subdivided in two subdomains: the proximal HCN subdomain and the extreme carboxy subdomain, HCC. HCC subdomain has a key role in binding of CNTs to the neuron gangliosides (8, 9)
All CNTs cleave the specific family of proteins integral to the exocytotic process [the soluble N-ethyl-maleimide-sensitive fusion (NSF) protein attachment receptor (SNARE) proteins] (10) and block neurotransmitter release and neurosecretion. Among the CNTs, TeNT inhibits the release of inhibitory neurotransmitter glycine and γ-aminobutyric acid through proteolytic cleavage of the neuronal SNARE protein synaptobrevin/ VAMP2 (5, 11, 12).
The humoral immune response plays a crucial role against tetanus and antibodies directed against multiple epitopes of TeNT involved in toxin neutralization (13). In this regard, production and characterization of different parts of tetanus toxin (especially LC and HCC subdomains) are important for understanding the intoxication mechanisms and also for production of neutralizing monoclonal antibodies.
Materials and Methods
Bacterial strains
E. coli strains JM109, Top10F’ and BL21 (DE3) (Novagen, Darmstadt, Germany) were cultured in LB agar containing 0.5% w/v yeast extract (Merck KGaA, Darmstadt, Germany), 1% w/v peptone (Merck KGaA, Darmstadt, Germany), 0.6% w/v NaCl and 1.5% w/v agar (Merck KGaA, Darmstadt, Germany). LB broth medium components were similar to LB agar except agar.
Construction and expression of the recombinant proteins
TeNT light chain and HCC subdomain of heavy chain were amplified from Clostridium tetani genomic DNA for construction of the recombinant proteins. Polymerase Chain Reaction (PCR) was performed using specific primers containing BamHI and HindIII restriction sites in both ends (shown as bold sequences): 5-GGATCCTATGCCAATAACCAT AAATAATTTTAG-3 as sense and 5-AAGCTTTG CAG TTC TATT ATA TA A ATT TTCTC-3 as antisense for LC and 5-GGATCCTTTATCTA TAACCTTTTTAAGAGACTTC-3 as sense and 5-AAGCTTAT CA TT TGTCCATCCTTCATCT G-3 as anti-sense for HCC.
PCR reactions were performed in 25 µl volumes using 1 unit/reaction pfu DNA polymerase (Fermentas, Moscow, Russia), 2.5 µl of 10 X PCR buffer, 1.5 µl of 25 mM MgSO4, 1.0 µl of dNTPs (10 mM) (Roche Applied Science, Indianapolis, USA), and 1 pmol of sense and anti-sense primers, respectively. Each amplification reaction underwent initial denaturation at 94°C for 5 min followed by 40 cycles at 94°C for 1 min, 54.7°C (light chain) and 57°C (HCC) for 1 min and 72°C for 1 min and 10 min at 72°C for the final extension. PCR products were finally visualized by electrophoresis over 1% agarose gel containing ethidium bromide. PCR products were extracted using the GF-1 Nucleic Acid Extraction Kit (Vivantis, Selangor Darul Ehsan, Malaysia). Gel-purified PCR products were directly cloned in pGEMT-easy cloning vector (Promega, Madison, USA) and transformed into E.coli JM109 or TOP10F’ competent cells. Sequencing of selected clones was performed using a BigDye Terminator Cycle Sequencing Reaction Kit (Applied Biosystems, Foster City, CA), and T7 and SP6 primers. After confirmation of the selected clones by sequencing, inserts were digested with restriction endonucleases BamHI and HindIII (Fermentas, Moscow, Russia) and ligated in pET28b(+) expression vector (Merck Millipore, Darmstadt, Germany). pET28b(+) light chain or HCC constructs were transformed into (E. coli) BL21 (DE3) expression host. Positive clones were selected by colony-PCR. The colony-PCR was performed in 25 cycles using Taq DNA polymerase instead of pfu DNA polymerase. After confirmation by colony- PCR, transformed cells were grown in LBbroth containing 50µg/ml kanamycin; 1-5mM IPTG (1, 2, 3, 4 and 5 mM) were used to induce protein production and finally after 2, 4 and 16 hr of incubation at 37°C, cells were harvested by centrifugation at 2000 g for 30 min at 4°C.
Purification of the recombinant proteins
Purification of recombinant proteins was performed using Nickel-Nitrilotriacetic Acid (Ni-NTA) chromatography column (Qiagen, Germantown, Maryland, USA) under denaturing condition. In this regard, harvested bacterial pellets containing inclusion bodies were solubilized in 20 ml of lysis buffer (100 mM NaH2PO4, 100 mM NaCl, 30 mM TrisHCL, pH = 8) and incubated on ice for 1 hr. This solution was continuously sonicated at 70% amplitude for 15 min for cell destruction and then centrifuged at 12000 g for 10 min at 4°C.
Pellets were resuspended in buffer A (100 mM NaH2PO4, 50 mM NaCl, 10 mM Tris- HCL, 30 mM imidazole, 8 M urea, pH = 8) and incubated at room temperature for 1 hr. After centrifugation at 18000 g, for 30 min at 4°C, supernatants were applied as starting materials on Ni-NTA agarose (Qiagen, Germantown, Maryland, USA) column equilibrated with buffer A.
Refolding process was accomplished using a continuous declining gradient of urea concentration from 8 M to zero for 3 hr. Subsequently, buffer B (100 mM NaH2PO4, 50 mM NaCl, 10 mM Tris-HCL, 80 mM imidazole, pH = 8) was used to detach nonspecific proteins from the column. Elution of target proteins was performed using buffer C (100 mM NaH2PO4, 50 mM NaCl, 10 mM Tris-HCL, 500 mM imidazole, pH = 8). Finally, purity of target proteins was checked using SDS-PAGE and protein concentrations were determined using BCA colorimetric assay kit (Pierce, Rockford, IL, USA).
Western blot analysis
Non-reducing SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of recombinant LC and HCC was carried out on a 12% polyacrylamide gel. Thereafter, proteins were transferred to PVDF or Nitrocellulose membranes(Merck KGaA, Darmstadt, Germany) at 100 V for 35 min using an electroblot system (BioRad, Hercules, California, USA).
After blocking the membrane with blocking buffer (PBS-T + 5% non-fat skim milk) overnight at 4°C, and then washing four times with PBS-T, human anti tetanus toxin polyclonal antibodies (prepared in our lab) were added at 10 µg/ml and the membrane was incubated with gentle rocking at RT for 1.5 hr. The membrane was then gently washed four times with PBS-T. After washing, HRP-conjugated sheep anti-human Ig solution (prepared in our lab) was added to membranes and incubation was performed under the same conditions of the primary antibodies. Finally each blot was developed using ECL detection kit (GE Healthcare Life Sciences, Uppsala, Sweden).
Characterization of recombinant H<sub>CC</sub> and LC proteins by ELISA
For final confirmation of the identity of recombinant HCC and LC proteins, ELISA was carried out using human anti-TeNT polyclonal and monoclonal antibodies, as described elsewhere (14). Briefly, ELISA plates were coated with appropriate concentration of recombinant HCC and LC (10 µg/ml), tetanus toxin (10 µg/ml) and toxoid (10 µg/ml) (Razi Vaccine and Serum Research Institute, Karaj, Iran) in Phosphate Buffer Saline (PBS, 0.15 M, pH = 7.2) overnight at 4°C. After washing, the plate was blocked using blocking buffer (PBS-Tween 20 containing 3% non-fat skim milk) at 37°C for 1.5 hr. After blocking and washing, 100 µl of 1 µg/ml purified human polyclonal and mouse monoclonal antibodies were added separately and incubated for 1.5 hr at 37°C. Appropriate dilution of HRPconjugated rabbit anti-human and rabbit antimouse (prepared in our lab) was subsequently added and the reaction was revealed with 3, 3′,5,5′-Tetramethylbenzidine (TMB) substrate. Finally, the reaction was stopped with 20% H2SO4 and the optical density (OD) was measured by a multiscan ELISA reader (Organon Teknika, Boxtel, Belgium) at 450 nm.
Discussion
Clostridial neurotoxins belong to classical A-B type toxins by their principal mode of action including an enzymatically active component, “A” and cell binding component “B” (15, 16).
Although molecular mechanism of TeNT toxicity is well characterized, the mechanism whereby TeNT binds to neurons requires more investigations. Several lines of evidence indicate that TeNT binding to its receptor depends on gangliosides (notably gangliosides of the 1 b series), and GPI-anchored glycoproteins (17–21). This gave direct support for involvement of a dual receptor mechanism in the binding of the TeNT in which gangliosides and glycosylated proteins such as synaptic vesicle proteins SV2A and SV2B are involved in TeNT binding. These components are present in both toxin-sensitive PC12 cells and spinal cord neurons (22). In this regards, application of recombinant DNA technology to produce different parts of TeNT could help to get better understanding of TeNT binding properties and neuronal activity.
In the present study, two recombinant fragments of TeNT were produced and purified. These two proteins play pivotal roles in intoxication and binding of TeNT to neuronal cells. LC cleaves the neuronal SNARE protein and blocks the release of inhibitory neurotransmitter which ultimately leads to spastic paralysis and HCC plays a key role in binding of TeNT to target cells (7). Our results showed that LC and HCC fragments were successfully expressed in (E. coli) BL21 (DE3) and efficiently purified by Ni-NTA chromatography. Recombinant HCC protein was expressed at high levels in (E. coli) BL21 (DE3) with approximately 25 kDa molecular weight (Figure 2A), whereas LC was only produced in very low amounts with approximately 50 kDa molecular weight (Figure 2B). These differences between LC and HCC expression may partly be explained by the fact that LC is the toxic part of TeNT and may have toxicity effect on growth of (E. coli) BL21(DE3). We proposed expression of LC using other expression vectors or expression systems such as yeast to overcome toxicity of the protein in (E. coli). In addition our results demonstrated that anti- TeNT polyclonal and monoclonal antibodies (mAbs) specifically react with recombinant LC and HCC proteins.
Two previously reported (14) anti TeNT light chain mAbs (1F3B3 and 1F3C3) recognized the recombinant LC whereas only one anti fragment C mAb (1F3E3) binds to recombinant HCC (Table 1). The second fragment Cspecific mAb (1F2C2) failed to react with the HCC subdomain. This mAb may either recognize a conformational epitope requiring both HCC and HCN subdomains for its expression or an epitope expressed in only HCN subdomain of fragment C. Alternatively, it may recognize a conformational epitope on HCC which might be lost due to denaturation by 8 M urea. Although the purified protein was renatured by a gradient of urea during the purification process (see the Materials and Methods), refolding of the protein might have been incomplete.